Publication Archive - Page 3 sur 18

Enhanced surveillance of hospitalized COVID-19 patients in Europe: an evaluation of the I-MOVE-COVID-19 surveillance network

Young JJ, Mutch H, Rose AMC, Evans JMM; European COVID-19 Hospital Evaluation Writing Group

Eur J Public Health. 2024 Feb 5;34(1):181-189. doi: 10.1093/eurpub/ckad185. PMID: 37889597; PMCID: PMC10843949.

Available here

Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the omicron BA.2.86/JN.1 period among older adults in seven European countries: a VEBIS-EHR network study

Nunes B, Humphreys J, Nicolay N, Braeye T, Van Evercooren I, Holm Hansen C, Moustsen-Helms IR, Sacco C, Fabiani M, Castilla J, Martínez-Baz I, Meijerink H, Machado A, Soares P, Ljung R, Pihlström N, Nardone A, Bacci S, Monge S; VEBIS-EHR working group; VEBIS EHR working group names

Expert Rev Vaccines. 2024 Nov 13. doi: 10.1080/14760584.2024.2428800doi:10.1080/14760584.2024.2428800.

Available here

Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS-CoV-2 Infection in Older Adults During the JN.1 Lineage-Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023–1 March 2024

Merdrignac, Lore and Lanièce Delaunay, Charlotte and Verdasca, Nuno and Vega-Pirisc, Lorena and O’Donnell, Joan and Sève, Noémie and Trobajo-Sanmartín, Camino and Buda, Silke and Hooiveld, Mariëtte and Rodrigues, Ana Paula and Túri, Gergő and Latorre-Margalef, Neus and Mlinarić, Ivan and Lazarm, Mihaela and Maurel, Marine and Castrillejo, Daniel and Bennett, Charlene and Rameix Welti, Marie-Anne and Martínez-Baz, Iván and Dürrwald, Ralf and Meijer, Adam and Melo, Aryse and Oroszi, Beatrix and Samuelsson Hagey, Tove and Kurečić Filipović, Sanja and Dijkstra, Frederika and Gomez, Verónica and Bacci, Sabrina and Kaczmarek, Marlena and Kissling, Esther

Influenza Other Respi Viruses, 18: e70009.

Available here

Effectiveness of the autumn 2023 COVID-19 vaccine dose in hospital-based healthcare workers: results of the VEBIS healthcare worker vaccine effectiveness cohort study, seven European countries, season 2023/24

Savulescu Camelia, Prats-Uribe Albert, Brolin Kim, Uusküla Anneli, Bergin Colm, Fleming Catherine, Murri Rita, Zvirbulis Viesturs, Zavadska Dace, Gaio Vania, Popescu Corneliu P, Hrisca Raluca, Cisneros Maria, Latorre-Millán Miriam, Lohur Liis, McGrath Jonathan, Ferguson Lauren, De Gaetano Donati Katleen, Abolina Ilze, Gravele Dagne, Machado Ausenda, Florescu Simin-Aysel, Lazar Mihaela, Subirats Pilar, Clusa Cuesta Laura, Sui Jacklyn, Kenny Claire, Santangelo Rosaria, Krievins Dainis, Barzdina Elza Anna, Valadas Henriques Camila, Kosa Alma Gabriela, Pohrib Saftica-Mariana, Muñoz-Almagro Carmen, Milagro Ana, Bacci Sabrina, Nardone Anthony, VEBIS HCW VE study group.

Euro Surveill. 2024;29(44):pii=2400680

Available here

COVID-19 vaccine effectiveness against SARS-CoV-2-confirmed hospitalisation in the eastern part of the WHO European Region (2022–2023): a test-negative case-control study from the EuroSAVE network

Mark A. Katz, Sandra Cohuet, Silvia Bino, Olgha Tarkhan-Mouravi, Besfort Kryeziu, Dinagul Otorbaeva, Kristina Stavridis, Maja Stosic, Jonilda Sulo, Ann Machablishvili, Ariana Kalaveshi, Abdyldaeva Sayragul Zhusupovna, Katerina Kolevska, Dragana Plavsa, Iris Hasibra, Khatuna Zakhashvili, Zana Kaçaniku-Deva, Uzakbaeva Aynura Zarylbekovna, Elizabeta Jancheska, Verica Jovanovic, James Humphreys, Jennifer Howard, Kirill Stolyarov, Oksana Artemchuk, Marc-Alain Widdowson, Iris Finci, Angela M.C. Rose, Richard Pebody, Iria Presa, Tamila Zardiashvili, Isme Humolli, Kaliya Kasymbekova, Goran Kochinski, Miljan Rancic

Europe, 2024, 101095, ISSN 2666-7762

Available here

Early COVID-19 XBB.1.5 Vaccine Effectiveness Against Hospitalisation Among Adults Targeted for Vaccination, VEBIS Hospital Network, Europe, October 2023–January 2024

Antunes L, Mazagatos C, Martínez-Baz I, Naesens R, Borg ML, Petrović G, Fatukasi T, Jancoriene L, Machado A, Oroszi B, Husa P, Lazar M, Dürrwald R, Howard J, Melo A, Pérez-Gimeno G, Castilla J, Bernaert E, Džiugytė A, Makarić ZL, Fitzgerald M, Mickienė A, Gomez V, Túri G, Součková L, Marin A, Tolksdorf K, Nicolay N, Rose AMC European Hospital Vaccine Effectiveness Group

Aug;18(8):e13360. doi: 10.1111/irv.13360. PMID: 39145535; PMCID: PMC11325250.

Available here

COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans

Charlotte Laniece Delaunay, PhD1; Clara Mazagatos, PhD2,3; Iván Martínez-Baz, PhD4; Gergő Túri, MSc5; Luise Goerlitz, MSc6; Lisa Domegan, PhD7; Adam Meijer, PhD8; Ana Paula Rodrigues, MSc9; Noémie Sève, MSc10; Maja Ilić, MD11; Neus Latorre-Margalef, PhD12; Mihaela Lazar, PhD13; Marine Maurel, MSc1; Aryse Melo, PhD14; Blanca Andreu Ivorra, MD, PhD15; Itziar Casado, MD, PhD4; Judit Krisztina Horváth, MD5; Silke Buda, MD6; Charlene Bennett, PhD16; Marit de Lange, PhD8; Raquel Guiomar, MSc14; Vincent Enouf, PhD17; Ivan Mlinarić, MD11; Tove Samuelsson Hagey, MSc12; Sorin Dinu, PhD13; Mercedes Rumayor, MD, PhD18; Jesús Castilla, MD, PhD4; Beatrix Oroszi, PhD5; Ralf Dürrwald, MD19; Joan O’Donnell, MB, MFPHMI7; Mariëtte Hooiveld, PhD20; Verónica Gomez, MSc9; Alessandra Falchi, PhD21; Sanja Kurečić Filipović, MD, PhD11; Lena Dillner, MD, PhD12; Rodica Popescu, MD22; Sabrina Bacci, MD23; Marlena Kaczmarek, PhD23; Esther Kissling, MSc1; for the VEBIS Primary Care Vaccine Effectiveness Group

JAMA Netw Open. 2024;7(7):e2419258. doi:10.1001/jamanetworkopen.2024.19258

Available here

Exploring the effect of clinical case definitions on influenza vaccine effectiveness estimation at primary care level: Results from the end-of-season 2022-23 VEBIS multicentre study in Europe

Maurel M, Mazagatos C, Goerlitz L, Oroszi B, Hooiveld M, Machado A, Domegan L, Ilić M, Popescu R, Sève N, Martínez-Baz I, Larrauri A, Buda S, Túri G, Meijer A, Gomez V, O’Donnell J, Mlinarić I, Timnea O, Diez AO, Dürrwald R, Horváth JK, Dijkstra F, Rodrigues AP, McKenna A, Filipović SK, Lazar M, Kaczmarek M, Bacci S, Kissling E; VEBIS study team.

Vaccine. 2024 Jun 11;42(16):3547-3554. doi: 10.1016/j.vaccine.2024.04.060. Epub 2024 May 3. PMID: 38704257; PMCID: PMC11152456.

Available here

Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: Results from the VEBIS primary care test-negative design study, September 2023–January 2024

Laniece Delaunay C, Melo A, Maurel M, Mazagatos C, Goerlitz L, O’Donnell J, Oroszi B, Sève N, Rodrigues AP, Martínez-Baz I, Meijer A, Mlinarić I, Latorre-Margalef N, Lazăr M, Pérez-Gimeno G, Dürrwald R, Bennett C, Túri G, Rameix-Welti MA, Guiomar R, Castilla J, Hooiveld M, Kurečić Filipović S, Samuelsson Hagey T, Dijkstra F, Borges V, Ramos Marín V, Bacci S, Kaczmarek M, Kissling E; European primary care VE group.

2024 Jun 4:S0264-410X(24)00644-3. doi: 10.1016/j.vaccine.2024.05.067. Epub ahead of print. PMID: 38839521.

Available here

BBIBP-CorV vaccine effectiveness against COVID-19 in patients aged 60 years and older during the Delta-dominant period in the Federation of Bosnia and Herzegovina, a test-negative case-control study

Sanjin Musa, Lore Merdrignac, Sinisa Skocibusic, Rozalija Nedic, Seila Cilovic-Lagarija, Esther Kissling

Received 31 January 2024, Revised 30 March 2024, Accepted 14 April 2024, Available online 21 April 2024, Version of Record 17 May 2024.

Available here

Publication

Référencement Centrales d'achats

Hébergement de données de santé

Engagement et éthique